Philip Morris International Inc. stock outperforms competitors on strong trading day
This was the stock's fifth consecutive day of gains.
bovnews3h
Why Is Philip Morris International Inc. (PM) Stock Lagging Behind -4.83% from Its 50-Day SMA?
Philip Morris International Inc. (PM) stock saw a modest uptick, ending the day at $119.8 which represents a slight increase of $1.29 or 1.09% from the prior close of $118.51. The stock opened at $118 ...
Philip Morris International Inc. (PM): A Bull Case Theory
We came across a bullish thesis on Philip Morris International Inc. (PM) on Substack by Chit Chat Stocks. In this article, we ...
Buy Rating for Philip Morris: Strategic Positioning and FDA Approval of ZYN Pouches
Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...
Stocktwits on MSN15h
Philip Morris Stock Rises On FDA Approval For Zyn Nicotine Pouches: Retail’s Upbeat
Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA ...
Hosted on MSN17h
Morgan Stanley Initiates Coverage of Philip Morris International (PM) with Overweight Recommendation
Fintel reports that on January 16, 2025, Morgan Stanley initiated coverage of Philip Morris International (NYSE:PM) with a ...
owensborotimes17h
FDA approves ZYN nicotine pouches; Owensboro facility at forefront of expansion
In a groundbreaking move for the industry, the FDA has authorized the marketing of ZYN nicotine pouches — the first product ...
FDA approves Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...
FDA Authorization of Flavored Zyn Products Ignores Appeal to Kids and Risks Another Juul
The FDA today has set a dangerous precedent that puts the nation's kids at risk by authorizing the sale of 20 Zyn nicotine ...
Philip Morris’s Zyn nicotine pouch isn’t safe, but FDA gives OK to marketing it
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
STAT1d
FDA authorizes sale of Zyn nicotine pouches, saying public health benefits outweigh risk
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...